A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 914
- 试验地点
- 2
- 主要终点
- Time to either hospital readmission or ER visit
研究概览
简要总结
The goal of this study is to assess the impact of pharmacist-led benefits investigations and application of clinical practice guidelines on patient access to inhalers and time to hospital readmission or Emergency Department (ED) visit.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patient admitted to Vanderbilt University Medical Center (VUMC) (excluding surgery services)
- •on a long acting inhaler or prescribed a long acting inhaler during admission.
排除标准
- •Diagnosis of cystic fibrosis
- •Diagnosis of graft versus host disease (GVHD)
- •no medication insurance
- •discharge to any post-acute care facility or inpatient hospice
- •death during hospitalization
研究组 & 干预措施
Pharmacist Intervention
Patients randomized to the intervention arm received usual care plus inhaler review by study pharmacist who made recommendations for inhaler changes based on clinical guideline and insurance formulary compliance. Recommendations were sent to the patient's team for final approval prior to discharge.
干预措施: Benefits investigation (Other)
Usual Care
Patients randomized to the usual care arm received care by the primary team which includes an inpatient pharmacist who does not have access to benefits investigation technology. The study pharmacist was not involved to review inhalers for optimization prior to discharge.
结局指标
主要结局
Time to either hospital readmission or ER visit
时间窗: 6 months
Combined time (days) to either hospital readmission or emergency department visit after hospitalization (all outcomes measured at 6 months post-discharge with a 3 month interim analysis)
次要结局
- frequency of prescribed inhaler at discharge(6 months)
- frequency of hospital readmissions(6 months)
- frequency of short course prescription of oral steroid(6 months)
- Frequency of ED visit(6 months)
- time to 1st ED visit (days)(6 months)
- time to 1st readmission (days)(6 months)
研究者
Tate Davis
Clinical Pharmacist
Vanderbilt University Medical Center